CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Stanford University
Stanford University
Dana-Farber Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
The First Affiliated Hospital of Soochow University
Sun Yat-sen University
University of Arizona
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Nebraska
Insel Gruppe AG, University Hospital Bern
The Lymphoma Academic Research Organisation
Medical University of Vienna
Florida International University
Ain Shams University
Masonic Cancer Center, University of Minnesota
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
The First Affiliated Hospital of Xiamen University
The First Affiliated Hospital of Xiamen University
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Ruijin Hospital
Université de Sherbrooke
University Medical Center Groningen
Zhejiang Provincial People's Hospital
University Medical Center Goettingen
Gruppo Italiano Malattie EMatologiche dell'Adulto
Australasian Leukaemia and Lymphoma Group
Peking Union Medical College Hospital
University Medical Center Groningen
Sunnybrook Health Sciences Centre
Florida International University
Centre Hospitalier Universitaire, Amiens
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Rush University Medical Center
Stanford University
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Case Comprehensive Cancer Center